Virtu Financial LLC Purchases Shares of 6,257 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Virtu Financial LLC acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,257 shares of the company’s stock, valued at approximately $248,000.

Several other large investors have also modified their holdings of the company. Wellington Management Group LLP lifted its position in Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after acquiring an additional 1,266,384 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. State Street Corp grew its holdings in Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after buying an additional 95,613 shares during the last quarter. Point72 Asset Management L.P. increased its position in Acadia Healthcare by 0.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after buying an additional 12,470 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of Acadia Healthcare by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after acquiring an additional 14,197 shares during the period.

Analyst Upgrades and Downgrades

ACHC has been the subject of several research analyst reports. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Bank of America reduced their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. TD Cowen lowered their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Finally, Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $43.00 to $35.00 in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $30.12 on Friday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.80 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 1.46 and a beta of 1.38. The firm’s 50 day moving average is $37.14 and its 200-day moving average is $45.28. Acadia Healthcare Company, Inc. has a 1 year low of $27.61 and a 1 year high of $82.41.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.